MedPath

UNIVERSITY OF ALABAMA AT BIRMINGHAM

🇺🇸United States
Ownership
-
Established
1969-01-01
Employees
2K
Market Cap
-
Website
http://www.uab.edu

The Interplay Between Oxalate, Immunity and Infection

Not Applicable
Not yet recruiting
Conditions
Kidney Stone
Interventions
Dietary Supplement: Low Oxalate Diet
Dietary Supplement: High Oxalate Diet
First Posted Date
2020-10-27
Last Posted Date
2024-12-19
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
88
Registration Number
NCT04605055

Chemo-embolization for Head and Neck Cancer

Phase 2
Not yet recruiting
Conditions
SCCHN
Squamous Cell Carcinoma
Interventions
First Posted Date
2020-10-22
Last Posted Date
2024-04-25
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
48
Registration Number
NCT04595981
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

Trial Comparing Impact of PENG Block on Quality of Recovery Compared to No-block for Primary Total Hip Arthroplasty

Phase 3
Completed
Conditions
Total Hip Arthroplasty
Interventions
Drug: PENG Block
Drug: Lidocaine
First Posted Date
2020-10-19
Last Posted Date
2024-02-15
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
122
Registration Number
NCT04591353
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response

Not Applicable
Recruiting
Conditions
Pancreatic Cancer
Interventions
Device: Point-of-care Portable Perfusion Phantom, P4
First Posted Date
2020-10-19
Last Posted Date
2024-10-09
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
55
Registration Number
NCT04588025
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

Tele-monitoring of Post Join Arthroplasty Outcomes: A Feasibility Study

Not Applicable
Completed
Conditions
Post-Op Complication
Interventions
Other: Telemedicine
First Posted Date
2020-10-14
Last Posted Date
2023-08-16
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
24
Registration Number
NCT04586296
Locations
🇺🇸

UAB Highland Hospital, Birmingham, Alabama, United States

VEGF and sFlt-1 Levels in the Pathogenesis and Severity of COVID-19 Disease

Recruiting
Conditions
COVID-19 Disease
First Posted Date
2020-10-14
Last Posted Date
2024-03-26
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
100
Registration Number
NCT04587323
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

Maximizing the Initial Experience of a Neophyte Scleral Lens Wearer

Not Applicable
Terminated
Conditions
Contact Lens Adaptation
Interventions
Device: DMV inserter (DMV® MagicTouch™) with an open end
Device: DMV inserter (DMV® MagicTouch™) with a closed end
Device: Three fingers (Patient's Hand)
Device: O-ring (Hardware Store Product)
Device: Tea light candle (Generic Deparment Store Product) with DMV inserter (DMV® MagicTouch™)
First Posted Date
2020-10-12
Last Posted Date
2024-07-18
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
17
Registration Number
NCT04583579
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

Impact of Theater Experience on Older Adults Living in Retirement Communities

Not Applicable
Completed
Conditions
Aging
Interventions
Behavioral: theater program
First Posted Date
2020-10-09
Last Posted Date
2024-12-13
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
84
Registration Number
NCT04582370
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS)

Not Applicable
Completed
Conditions
ARDS
Covid19
Acute Hypoxemic Respiratory Failure
Interventions
Other: Prolonged Proned Positioning
Other: Traditional Proning Arm
First Posted Date
2020-10-09
Last Posted Date
2022-03-31
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
52
Registration Number
NCT04581811
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

The Effect of Guanfacine on Delirium in Critically Ill Patients

Phase 3
Completed
Conditions
Delirium
Interventions
Drug: Placebo
Drug: Guanfacine
First Posted Date
2020-10-08
Last Posted Date
2024-07-25
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
100
Registration Number
NCT04578886
Locations
🇺🇸

University of Alabama at Birmingham Hospital, Birmingham, Alabama, United States

© Copyright 2025. All Rights Reserved by MedPath